Pristimerin Protects Against OVX-Mediated Bone Loss by Attenuating Osteoclast Formation and Activity via Inhibition of RANKL-Mediated Activation of NF-κB and ERK Signaling Pathways.
There is growing appreciation of the functional capabilities of astrocytes, as recent studies demonstrate their participation in previously overlooked cellular processes like synapse remodeling, ...